• Quotes

  • NAVs

  • News

  • Messages

  • Opinions

  • Notices

  • Videos

Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17021.85 236.20 NIFTY 5052.45 63.45
 

Ranbaxy Laboratories Profit & Loss account, Ranbaxy Laboratories Financial Statement & Accounts
You are here : Moneycontrol » Markets » Profit & Loss account - Ranbaxy Laboratories

Ranbaxy Laboratories

BSE: 500359  |  NSE: RANBAXY  |  ISIN: INE015A01028  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Profit & Loss account of Ranbaxy Laboratories

 ------------------- in Rs. Cr. -------------------
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
12 mths 12 mths 12 mths 12 mths 12 mths
Income
Sales Turnover 3,865.86 3,727.05 4,218.98 4,344.39 4,676.21
Excise Duty 74.58 86.56 53.86 51.37 24.17
Net Sales 3,791.28 3,640.49 4,165.12 4,293.02 4,652.04
Other Income 64.78 122.25 -28.65 551.13 -1,587.64
Stock Adjustments 82.82 30.96 44.70 40.66 115.59
Total Income 3,938.88 3,793.70 4,181.17 4,884.81 3,179.99
Expenditure
Raw Materials 1,566.68 1,567.55 1,708.23 1,861.17 2,049.30
Power & Fuel Cost 62.67 69.55 80.70 90.35 108.83
Employee Cost 324.01 298.38 328.45 420.04 472.65
Other Manufacturing Expenses 68.68 67.09 79.52 82.60 94.65
Selling and Admin Expenses 1,143.13 1,339.12 1,234.42 1,341.03 1,402.77
Miscellaneous Expenses 76.28 144.32 146.23 123.90 383.26
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 3,241.45 3,486.01 3,577.55 3,919.09 4,511.46
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
12 mths 12 mths 12 mths 12 mths 12 mths
Operating Profit 632.65 185.44 632.27 414.59 256.17
PBDIT 697.43 307.69 603.62 965.72 -1,331.47
Interest 10.98 26.41 58.44 93.43 145.83
PBDT 686.45 281.28 545.18 872.29 -1,477.30
Depreciation 81.85 101.33 106.75 118.73 154.47
Other Written Off 0.00 0.00 0.00 0.00 0.00
Profit Before Tax 604.60 179.95 438.43 753.56 -1,631.77
Extra-ordinary items 26.74 12.72 19.34 35.46 17.76
PBT (Post Extra-ord Items) 631.34 192.67 457.77 789.02 -1,614.01
Tax 99.87 -22.34 62.43 156.69 -574.24
Reported Net Profit 527.52 212.04 380.54 617.72 -1,044.80
Total Value Addition 1,674.77 1,918.46 1,869.31 2,057.93 2,462.16
Preference Dividend 0.00 0.00 0.00 0.00 0.00
Equity Dividend 316.26 316.67 316.89 317.15 0.00
Corporate Dividend Tax 44.04 44.41 44.44 53.90 0.00
Per share data (annualised)
Shares in issue (lakhs) 1,858.91 3,724.42 3,726.87 3,730.71 4,203.70
Earning Per Share (Rs) 28.38 5.69 10.21 16.56 -24.85
Equity Dividend (%) 170.00 170.00 170.00 170.00 0.00
Book Value (Rs) 134.85 63.82 63.03 68.01 84.24
Source : Religare Technova
Explore Ranbaxy Labs connections